Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 646540, 5 pages
http://dx.doi.org/10.1093/ecam/nep211
Case Report

Herbal Medicine Containing Licorice May Be Contraindicated for a Patient with an HSD11B2 Mutation

1Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
2Daikakuji Clinic, Kobe University Graduate School of Medicine, Tottori, Japan
3Usuki Clinic, Kobe University Graduate School of Medicine, Kobe, Japan
4Department of Hospital Pharmacy, Kobe University Graduate School of Medicine, Japan
5Division of Applied Genome Science and Bioinformatics, Kobe University Graduate School of Medicine, Kobe, Japan
6Nishimoto Clinic, Nishinomiya, Japan

Received 18 August 2009; Accepted 9 November 2009

Copyright © 2011 Indra Sari Kusuma Harahap et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Kim, S. J. Park, J. R. Lee, J. C. Seo, C. H. Yang, and S. H. Byun, “Cytoprotective activity of Glycyrrhizae radix extract against arsenite-induced cytotoxicity,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 2, pp. 165–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Lee, S. J. Park, H.-S. Lee et al., “Hepatoprotective activity of licorice water extract against Cadmium-induced toxicity in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 2, pp. 195–201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. White, T. Mune, and A. K. Agarwal, “11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess,” Endocrine Reviews, vol. 18, pp. 135–156, 1997. View at Google Scholar
  4. P. M. Stewart, R. Valentino, A. M. Wallace, D. Burt, C. H. L. Shackleton, and C. R. W. Edwards, “Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age,” The Lancet, vol. 2, no. 8563, pp. 821–824, 1987. View at Google Scholar · View at Scopus
  5. M. A. MacKenzie, W. H. Hoefnagels, R. W. Jansen, T. J. Benraad, and P. W. Kloppenborg, “The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers,” Journal of Clinical Endocrinology & Metabolism, vol. 70, pp. 1637–1643, 1990. View at Google Scholar
  6. F. Hammer and P. M. Stewart, “Cortisol metabolism in hypertension,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 20, no. 3, pp. 337–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. M. Stewart, J. E. T. Corrie, C. H. L. Shackleton, and C. R. W. Edwards, “Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle,” The Journal of Clinical Investigation, vol. 82, no. 1, pp. 340–349, 1988. View at Google Scholar · View at Scopus
  8. S. H. M. Van Uum, A. R. M. M. Hermus, P. Smits, T. Thien, and J. W. M. Lenders, “The role of 11β-hydroxysteroid dehydrogenase in the pathogenesis of hypertension,” Cardiovascular Research, vol. 38, no. 1, pp. 16–24, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Mune, F. M. Rogerson, H. Nikkila, A. K. Agarwal, and P. C. White, “Human hypertension caused by mutations in the kidney isozyme of 11β- hydroxysteroid dehydrogenase,” Nature Genetics, vol. 10, no. 4, pp. 394–399, 1995. View at Google Scholar · View at Scopus
  10. G. G. Lavery, V. Ronconi, N. Draper et al., “Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene,” Hypertension, vol. 42, no. 2, pp. 123–129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. C. Wilson, M. D. Harbison, Z. S. Krozowski et al., “Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess,” Journal of Clinical Endocrinology & Metabolism, vol. 80, pp. 3145–3150, 1995. View at Google Scholar
  12. R. C. Wilson, S. Dave-Sharma, J.-Q. Wei et al., “A genetic defect resulting in mild low-renin hypertension,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 17, pp. 10200–10205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Dave-Sharma, R. C. Wilson, M. D. Harbison et al., “Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess,” Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 7, pp. 2244–2254, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Odermatt, B. Dick, P. Arnold et al., “A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension,” Journal of Clinical Endocrinology & Metabolism, vol. 86, pp. 1247–1252, 2001. View at Google Scholar
  15. P. M. Stewart, Z. S. Krozowski, A. Gupta et al., “Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene,” The Lancet, vol. 347, no. 8994, pp. 88–91, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Kamide, Y. Kokubo, H. Hanada et al., “Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense/frameshift mutations,” Hypertension Research, vol. 29, no. 4, pp. 243–252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Gunadi, K. Miura, M. Ohta et al., “Two novel mutations in the ED1 gene in Japanese families with X-linked hypohidrotic ectodermal dysplasia,” Pediatric Research, vol. 65, no. 4, pp. 453–457, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Yasue, T. Itoh, Y. Mizuno, and E. Harada, “Severe hypokalemia, rhabdomyolysis, muscle paralysis, and respiratory impairment in a hypertensive patient taking herbal medicines containing licorice,” Internal Medicine, vol. 46, no. 9, pp. 575–578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. G. Gerritsen, J. Meulenbelt, W. Spiering, I. P. Kema, A. Demir, and V. J. van Driel, “An unusual cause of ventricular fibrillation,” The Lancet, vol. 373, no. 9669, p. 1144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. R. Prezant, J. V. Agapian, M. C. Bohlman et al., “Mitochondrial ribosomal RNA mutation associated with both antibiotic- induced and non-syndromic deafness,” Nature Genetics, vol. 4, no. 3, pp. 289–294, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-I. Usami, S. Abe, H. Shinkawa, Y. Inoue, and T. Yamaguchi, “Rapid mass screening method and counseling for the 1555A→G mitochondrial mutation,” Journal of Human Genetics, vol. 44, no. 5, pp. 304–307, 1999. View at Publisher · View at Google Scholar · View at Scopus